Aytu Biopharma AYTU
NASDAQ AYTU
$2.20 +0.03 (+1.38%)
At close: Sep 29, 2026 · 4:00 PM EDT

Aytu Biopharma (AYTU) Total Current Liabilities (2011 - 2026)

Updated

Aytu Biopharma's Total Current Liabilities was $54.66 million in fiscal Q4 2026 (quarter ended Jun 30, 2026), down 13.3% from $63.06 million a year earlier and down 8.9% from the prior quarter.

Analysis

Aytu Biopharma (AYTU) Total Current Liabilities (2011 - 2026) Analysis & Trends

From fiscal Q4 2011 onward, Aytu Biopharma has reported Total Current Liabilities for 57 quarters.

  • Total Current Liabilities shows a five-year compound annual growth rate of -13.0% (FY2021 to FY2026).
  • In earlier fiscal years, Total Current Liabilities was $63.06 million in FY2025 (+1.3%), $62.23 million in FY2024 (-9.8%), $69.02 million in FY2023 (+7.1%) and $64.44 million in FY2022 (-41.1%).
  • The fiscal Q4 2026 figure marks the lowest quarterly Total Current Liabilities since fiscal Q2 2021.
  • Compared with a year earlier, Total Current Liabilities was higher in three of the last eight quarters, with an average decline of 4.9%.
  • The best year-over-year quarter for Total Current Liabilities over five years was fiscal Q1 2022 (growth of 355.7%); the worst was fiscal Q4 2022 (a decline of 41.1%).
  • Per Business Quant data, AYTU's Total Current Liabilities in the three fiscal quarters before Q4 2026 was $59.97 million (Q3 2026), $65.56 million (Q2 2026) and $65.99 million (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Current Liabilities (Qtr)
1 Johnson & Johnson 655.56 Bn 574.09 Bn 17.26 Bn 54.90 Bn
2 AbbVie 470.94 Bn 444.10 Bn 12.70 Bn 41.64 Bn
3 Merck 367.14 Bn 321.57 Bn 12.21 Bn 27.73 Bn
4 Novartis Ag 280.33 Bn 236.20 Bn 11.24 Bn 31.75 Bn
5 Astrazeneca 257.78 Bn 231.34 Bn 12.86 Bn -31.55 Bn
6 Amgen 226.04 Bn 181.44 Bn 7.24 Bn 25.50 Bn
7 Gilead Sciences 188.89 Bn 163.01 Bn 6.22 Bn 11.02 Bn
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn 32.65 Bn
9 Vertex Pharmaceuticals 133.68 Bn 105.69 Bn 2.84 Bn 3.94 Bn
10 Aytu Biopharma 23.58 Mn -92.10 Mn 10.41 Mn 54.66 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 54.66 Mn
Mar 31, 2026 59.97 Mn
Dec 31, 2025 65.56 Mn
Sep 30, 2025 65.99 Mn
Jun 30, 2025 63.06 Mn
Mar 31, 2025 70.71 Mn
Dec 31, 2024 64.05 Mn
Sep 30, 2024 61.25 Mn
Jun 30, 2024 62.23 Mn
Mar 31, 2024 83.69 Mn
Dec 31, 2023 64.19 Mn
Sep 30, 2023 65.46 Mn
Jun 30, 2023 69.02 Mn
Mar 31, 2023 85.42 Mn
Dec 31, 2022 67.15 Mn
Sep 30, 2022 73.20 Mn
Jun 30, 2022 64.44 Mn
Mar 31, 2022 80.36 Mn
Dec 31, 2021 100.57 Mn
Sep 30, 2021 98.00 Mn
API Access

Aytu Biopharma Total Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=total-current-liabilities&ticker=AYTU&period=max&api_key=YOUR_API_KEY